Analgesics in the Middle East & Africa
The Middle East & Africa (MEA) was the second-fastest growing market for analgesics over the review period of 2012-2017, posting a historic CAGR of 3%, and exceeded only in speed by Asia Pacific. Growth in the region is driven largely by an expanding middle class with more disposable income to spend on OTC products, and an emphasis on preventive public health measures by governments, that has contributed to an absolute retail sales value gain of USD398 million across the region over 2012-2017.
Euromonitor International’s Analgesics in the Middle East & Africa global briefing examines the size, growth trends and potential opportunities in the Consumer Health market. The strategic analyses include assessing the impacts of changing regulations, research breakthroughs and public health concerns on both the market and leading companies. Consumer attitudes towards the products and their personal healthcare needs are also explored.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook